The Empirical Labs representatives are consistently friendly and continue to go above and beyond to ensure quality service
Clinical Evidence for Non-Diabetic GLP-1 Use Randomized controlled trials including the STEP program demonstrated GLP-1 agonists produce average weight loss of 10-15% in non-diabetic obese and overweight populations
Published scientific literature discusses GHK-Cu in relation to copper peptide research, peptide chemistry, gene expression studies, molecular biology, receptor biology, cellular communication, and analytical peptide characterization
This is why many people look for "reduced" glutathione or liposomal versions
Contact us to book your appointment for hormone replacement therapy or vitamin B12 injections
Reduction of Inflammation and Oxidative Stress : BPC-157 and TB-500 work synergistically to reduce inflammatory cytokines such as TNF- and IL-6 and to mitigate oxidative stress markers in damaged tissues